Absci (ABSI) Current Deferred Revenue (2020 - 2026)
Absci (ABSI) reported Current Deferred Revenue of $1.0 million for Q1 2026, down 9.09% on a YoY basis from $1.1 million in Q1 2025, and up 35.32% sequentially from $739000.0 in Q4 2025.
Absci (ABSI) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Current Deferred Revenue data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue fell 9.09% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (down 9.09% YoY), and the FY2025 full-year result was $739000.0, down 32.82% from the prior year.
- Current Deferred Revenue improved to $1.0 million in Q1 2026, from $739000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $4.1 million in Q4 2023 to a low of $345000.0 in Q3 2023.
- A 5-year average of $1.5 million and a median of $1.1 million in 2024 frame the typical range for Current Deferred Revenue.
- Peak annual rise in Current Deferred Revenue reached 821.35% in 2023, while the deepest fall reached 87.14% in 2023.
- Tracing ABSI's Current Deferred Revenue over 5 years: stood at $445000.0 in 2022, then soared by 821.35% to $4.1 million in 2023, then slumped by 73.17% to $1.1 million in 2024, then tumbled by 32.82% to $739000.0 in 2025, then surged by 35.32% to $1.0 million in 2026.
- Business Quant data shows ABSI's Current Deferred Revenue at $1.0 million in Q1 2026, $739000.0 in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 739,000.00 |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 954,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Sep 30, 2023 | 345,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 359,000.00 |
| Dec 31, 2022 | 445,000.00 |
| Sep 30, 2022 | 679,000.00 |
| Jun 30, 2022 | 2.80 Mn |
| Mar 31, 2022 | 2.79 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.97 Mn |
| Jun 30, 2021 | 1.78 Mn |